Target intelligence / Profile preview

DNA-directed RNA polymerase subunit beta, bacterial-type

Molecular classification
Enzyme, Transcription factor (as a core component of the transcriptional machinery), Polymerase
01

Overview

DNA-directed RNA polymerase subunit beta, bacterial-type, is a core enzymatic subunit of the bacterial RNA polymerase complex encoded by the rpoB gene[2][6][7]. It forms part of the active center responsible for the catalysis of RNA synthesis during transcription, working in concert with the beta', alpha, and omega subunits to convert DNA sequences into RNA transcripts[2][3][4][5]. The beta subunit is essential for life in bacteria and is directly targeted by antibiotics like rifampicin, making it a crucial focus for antibacterial drug design and resistance profiling[4][3][7].

Other names
RNA polymerase beta subunit, bacterial-typerpoB gene productDNA-dependent RNA polymerase beta subunitRNAP βBeta subunit of bacterial RNA polymerase
02

Mechanism of action

Inhibition of RNA polymerase activity by preventing initiation or elongation of RNA synthesis (e.g., rifampicin binds to the beta subunit, blocking the RNA exit tunnel and preventing RNA chain elongation[4][3][7]) Disruption of the formation or function of the transcriptional machinery

03

Biological functions

Catalysis of RNA synthesisTranscription of DNA into RNAGene expression regulation (through transcription)
04

Disease associations

Infection (targeted in bacterial infections)Other (implicated in resistance to antibacterial agents)
05

Safety considerations

Emergence of drug resistance (notably via rpoB mutations)Off-target effects leading to toxicity or disturbances in human microbiotaNarrow spectrum of some inhibitors
06

Interacting drugs

Rifampicin

4 more in the full profile.

07

Biomarkers

rpoB mutations (biomarker for rifampicin resistance in tuberculosis and other bacteria)

Beyond the preview

Go deeper on DNA-directed RNA polymerase subunit beta, bacterial-type.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-directed RNA polymerase subunit beta, bacterial-type.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call